Cardiovascular Diseases

At Futuremeds Targówek, researchers are assessing new anticoagulant strategies for atrial fibrillation to reduce stroke risk.

  • Evaluation of milvexian versus apixaban for cardioembolic event prevention
  • Investigation of composite outcomes of stroke and systemic embolism

The work supports safer treatment options for patients with heart rhythm disorders.

Skin and Connective Tissue Diseases

The site conducts long‑term safety studies of novel oral agents for moderate‑to‑severe plaque psoriasis, aiming to improve disease control.

  • Safety and tolerability of TAK‑279 in chronic skin disease
  • Evaluation of treatment effectiveness over extended periods

These trials help expand therapeutic choices for individuals living with persistent skin conditions.

Bacterial Infections and Mycoses

Investigators evaluate the immunogenicity of a 21‑valent pneumococcal conjugate vaccine in children, supporting better protection against pneumococcal infection.

  • Serotype‑specific IgG antibody response after vaccination
  • Opsonophagocytic activity across different pediatric age groups

Futuremeds Targówek contributes to public‑health vaccination strategies for infants, toddlers, children, and adolescents.